Daesung Private Equity Inc

Daesung Private Equity Inc has a low debt-to-equity ratio of 0.0 and a high current ratio of 103.75, indicating strong liquidity and minimal leverage. The company's price-to-book ratio is 0.83, suggesting that the market value is trading below the book value, which may reflect market skepticism or conservative valuation expectations. The company's profitability is modest, with a return on equity (ROE) of 0.0032 and a return on assets (ROA) of 0.0032. These metrics are below the typical thresholds for high-performing investment management firms, indicating that the company is generating limited returns relative to its equity and asset base. Daesung Private Equity Inc's revenue is concentrated in its core venture capital and investment management activities, with no disclosed geographic diversification. The company's operations are primarily based in Korea, and there is no indication of significant international revenue streams or segment diversification. The company's growth trajectory is not clearly defined, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's operating cash flow is negative at -11,929,043,610 KRW, which may indicate that the company is reinvesting heavily in its operations or facing temporary cash flow challenges. The risk assessment for Daesung Private Equity Inc indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is stable, with minimal long-term debt and a high proportion of equity. However, the company's high price-to-earnings ratio of 260.51 suggests that the market is valuing the company at a premium relative to its earnings, which may be a point of concern for investors. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's last actual EPS was 30.79 KRW, which is a key metric for assessing its earnings performance. There are no recent transcripts or filings that suggest material changes in the company's strategic direction or financial health.